Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Alan Walker currently holds 15,843,021 shares of GreenLight Biosciences Holdings, PBC (GRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Alan Walker has been a net buyer of GRNA stock. They have purchased $15.0M and sold $0 worth of shares.
Matthew Alan Walker's most recent insider trade was on Feb 2, 2022, when they purchased 1,500,000 shares at $10.00 per share.
Matthew Alan Walker serves as Executive at GreenLight Biosciences Holdings, PBC (GRNA). They have executed 2 insider transactions totaling $15.0M over their tenure at the company.
Matthew Alan Walker holds the position of Executive at GreenLight Biosciences Holdings, PBC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Matthew Alan Walker has shown a buying trading pattern, with $15.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Matthew Alan Walker was on Feb 2, 2022, when they purchased $15.0M worth of GRNA shares. This transaction involved 1,500,000 shares at $10.00 per share.
Matthew Alan Walker currently owns 15,843,021 shares of GreenLight Biosciences Holdings, PBC (GRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Alan Walker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Alan Walker has 2 Form 4 filings on record as an insider at GreenLight Biosciences Holdings, PBC.
Set alerts for Matthew Alan Walker and 40,000+ other insiders.